Oral simvastatin treatment in relapsing-remitting multiple sclerosis Oral simvastatin treatment in relapsing-remitting multiple sclerosis2018-01-17T17:06:09-05:00
The initiation of the autoimmune response in multiple sclerosis The initiation of the autoimmune response in multiple sclerosis2018-01-17T17:05:49-05:00
The initiation of the autoimmune response in multiple sclerosis The initiation of the autoimmune response in multiple sclerosis2018-01-17T17:05:43-05:00
Molecular Mimicry and Antigen-Specific T Cell Responses in Multiple Sclerosis and Chronic CNS Lyme Disease Molecular Mimicry and Antigen-Specific T Cell Responses in Multiple Sclerosis and Chronic CNS Lyme Disease2018-01-17T17:05:23-05:00
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon B Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon B2018-01-17T17:00:33-05:00
